U.S., May 13 -- ClinicalTrials.gov registry received information related to the study (NCT07581652) titled 'ICGA for Vascular Embolism After Hyaluronic Acid Injection' on April 28.
Brief Summary: Facial vascular embolism following hyaluronic acid injection is a rare but potentially serious complication that may lead to tissue ischemia, necrosis, and scarring. Early assessment of local tissue perfusion is important for evaluating treatment response and predicting clinical outcomes.
This retrospective observational study aims to evaluate whether indocyanine green angiography (ICGA) can provide objective, real-time information on tissue perfusion in patients with facial vascular embolism after hyaluronic acid injection. The study will review...